10. |
ACCRUED
EXPENSES AND LONG-TERM LIABILITIES |
Other
accrued expenses consisted of the following as of September 30, 2022 and December 31, 2021:
SCHEDULE OF OTHER ACCRUED EXPENSES
|
|
September 30, 2022 |
|
|
December 31, 2021 |
|
|
|
|
(unaudited) |
|
|
|
|
|
Accrued royalties |
|
$ |
4,675 |
|
|
$ |
3,890 |
|
Contingent consideration |
|
|
509 |
|
|
|
488 |
|
Operating lease liability |
|
|
668 |
|
|
|
762 |
|
Interest payable |
|
|
122 |
|
|
|
120 |
|
Warrant liability |
|
|
- |
|
|
|
71 |
|
Accrued sales and marketing - diagnostics |
|
|
47 |
|
|
|
47 |
|
Accrued lab costs - diagnostics |
|
|
136 |
|
|
|
228 |
|
Accrued professional fees |
|
|
699 |
|
|
|
932 |
|
Taxes payable |
|
|
85 |
|
|
|
222 |
|
Unclaimed property |
|
|
565 |
|
|
|
565 |
|
All others |
|
|
869 |
|
|
|
1,137 |
|
Total other accrued expenses |
|
$ |
8,375 |
|
|
$ |
8,462 |
|
Long-term
liabilities consisted of the following as of September 30, 2022 and December 31, 2021:
SCHEDULE OF LONG TERM LIABILITIES
|
|
September 30, 2022 |
|
|
December 31, 2021 |
|
|
|
(unaudited) |
|
|
|
|
Uncertain tax positions |
|
$ |
4,736 |
|
|
$ |
4,577 |
|
Other |
|
|
- |
|
|
|
- |
|
Total other long-term liabilities |
|
$ |
4,736 |
|
|
$ |
4,577 |
|
|